Parkinson’s disease is often associated with later life, typically emerging in the 60s, but it doesn’t adhere to age. A significant, though smaller, number of individuals experience the onset of symptoms before reaching 50, a reality recently brought to the forefront by Rebecca King Crews.
The wife of actor Terry Crews, Rebecca, 60, bravely revealed her decade-long battle with Parkinson’s. Her journey began subtly in 2012, with initial symptoms easily overlooked. It wasn’t until 2015 that a formal diagnosis confirmed her fears.
During a recent interview, King Crews shared the frustrating early stages of her illness. A slight numbness in her left foot was the first sign, followed by a diminished arm swing noticed by her trainer. Then came the unmistakable tremor in her hand, a chilling echo of her grandmother’s experience.
Initially, her concerns were dismissed as anxiety. Multiple visits to different doctors followed, a common experience for those with Parkinson’s, as the disease often masquerades as other conditions. The path to diagnosis can be long and arduous.
Parkinson’s is relatively uncommon in younger individuals; only around 2% are diagnosed before age 40, and roughly 4% before 50. However, the overall number of Americans living with the disease is substantial – an estimated 1.1 million, a figure projected to climb to 1.2 million by 2030.
The disease unfolds gradually, typically presenting with tremors, muscle rigidity, slowed movement, and balance difficulties. But experts now understand that Parkinson’s often begins with far more subtle cues, extending beyond motor symptoms.
Those with young-onset Parkinson’s, or YOPD, frequently experience dystonia – involuntary muscle contractions – and more non-motor symptoms. Interestingly, YOPD patients often maintain cognitive function for a longer period and experience a slower overall disease progression.
Neurologists are increasingly aware that Parkinson’s “announces itself subtly.” Changes in handwriting – becoming smaller and cramped – a diminished sense of smell, sleep disturbances, constipation, and a softer voice can all be early indicators. These seemingly unrelated symptoms can easily be missed or misattributed.
The underlying cause of Parkinson’s remains a mystery, but genetic factors appear to play a slightly larger role in YOPD cases. Emerging research also points to potential links between early-onset disease and environmental exposures, like pesticides, certain chemicals, and even head trauma.
While there’s no known way to prevent Parkinson’s, evidence suggests that regular exercise may help slow its progression. And now, new treatments are offering hope, like the recently FDA-approved bilateral-focused ultrasound that Rebecca King Crews has undergone.
This innovative therapy utilizes focused ultrasound waves, guided by MRI, to target areas of the brain affected by Parkinson’s. Approved in July 2025 for treating both sides of the brain, it represents a significant advancement, though it’s not a cure.
Focused ultrasound is a costly procedure, and insurance coverage isn’t always guaranteed. Experts emphasize the importance of discussing candidacy with a movement disorder specialist and advocating for access to this promising technology.
Despite the challenges, there’s growing optimism within the medical community. Ongoing research into neuroprotective therapies offers the potential to alter the course of the disease. The landscape of Parkinson’s treatment is rapidly evolving.
The key message is clear: don’t suffer in silence. Seek expert evaluation, stay informed about the latest advancements, and actively engage in your care. The future of Parkinson’s treatment is brimming with possibility.
